Quest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025
Quest Diagnostics (NYSE: DGX) has scheduled the release of its fourth quarter and full year 2024 financial results for Thursday, January 30, 2025, before market opening. The company will host a conference call at 8:30 a.m. Eastern Time to discuss the results.
Participants can join the call by dialing 888-455-0391 (U.S. and Canada) or 773-756-0467 (international) using passcode '7895081'. The earnings release and webcast will be available on Quest's investor website. A replay will be accessible until February 13, 2025, via phone or the company's investor website.
Quest Diagnostics (NYSE: DGX) ha programmato il rilascio dei suoi risultati finanziari del quarto trimestre e dell'intero anno 2024 per giovedì 30 gennaio 2025, prima dell'apertura del mercato. L'azienda ospiterà una conferenza telefonica alle 8:30 del mattino, ora orientale, per discutere i risultati.
I partecipanti possono unirsi alla chiamata componendo il numero 888-455-0391 (U.S. e Canada) o 773-756-0467 (internazionale) utilizzando il codice d'accesso '7895081'. Il comunicato sugli utili e la trasmissione in diretta saranno disponibili sul sito web per gli investitori di Quest. Una registrazione sarà accessibile fino al 13 febbraio 2025, tramite telefono o sul sito web per gli investitori dell'azienda.
Quest Diagnostics (NYSE: DGX) ha programado la publicación de sus resultados financieros del cuarto trimestre y del año completo 2024 para el jueves 30 de enero de 2025, antes de la apertura del mercado. La empresa realizará una llamada de conferencia a las 8:30 a.m. hora del Este para discutir los resultados.
Los participantes pueden unirse a la llamada marcando el 888-455-0391 (EE. UU. y Canadá) o el 773-756-0467 (internacional) utilizando el código de acceso '7895081'. El comunicado de ganancias y la transmisión en directo estarán disponibles en el sitio web de inversores de Quest. Una repetición estará accesible hasta el 13 de febrero de 2025, a través del teléfono o en el sitio web de inversores de la empresa.
Quest Diagnostics (NYSE: DGX)는 2024년 4분기 및 연간 재무 결과를 2025년 1월 30일 목요일 시장 개장 전에 발표할 예정입니다. 회사는 결과를 논의하기 위해 동부 표준시 기준 오전 8시 30분에 전화 회의를 진행합니다.
참가자들은 통신 비밀번호 '7895081'을 사용하여 888-455-0391 (미국 및 캐나다) 또는 773-756-0467 (해외)로 전화하여 회의에 참여할 수 있습니다. 수익 발표 및 웹캐스트는 Quest의 투자자 웹사이트에서 이용 가능할 것입니다. 재방송은 2025년 2월 13일까지 전화 또는 회사의 투자자 웹사이트를 통해 이용할 수 있습니다.
Quest Diagnostics (NYSE: DGX) a prévu la publication de ses résultats financiers du quatrième trimestre et de l'année complète 2024 pour le jeudi 30 janvier 2025, avant l'ouverture des marchés. L'entreprise organisera une conférence téléphonique à 8h30, heure de l'Est, pour discuter des résultats.
Les participants peuvent rejoindre l'appel en composant le 888-455-0391 (États-Unis et Canada) ou le 773-756-0467 (international) en utilisant le code d’accès '7895081'. Le communiqué de résultats et le webinaire seront disponibles sur le site des investisseurs de Quest. Un replay sera accessible jusqu'au 13 février 2025, par téléphone ou via le site des investisseurs de l'entreprise.
Quest Diagnostics (NYSE: DGX) hat die Veröffentlichung seiner finanziellen Ergebnisse für das vierte Quartal und das gesamte Jahr 2024 für Donnerstag, den 30. Januar 2025, vor der Eröffnung der Märkte angesetzt. Das Unternehmen wird um 8:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Teilnehmer können an dem Anruf teilnehmen, indem sie 888-455-0391 (USA und Kanada) oder 773-756-0467 (international) wählen und den Zugangscode '7895081' verwenden. Die Ergebnisveröffentlichung und der Webcast werden auf der Investorenseite von Quest verfügbar sein. Eine Wiederholung wird bis zum 13. Februar 2025 per Telefon oder über die Investorenseite des Unternehmens zugänglich sein.
- None.
- None.
The conference call can be accessed by dialing 888-455-0391 within the
A replay of the call may be accessed online at www.QuestDiagnostics.com/investor or by phone at 866-360-8701 for domestic callers or 203-369-0179 for international callers; no passcode is required. Telephone replays will be available from approximately 10:30 a.m. Eastern Time on January 30, 2025 until midnight Eastern Time on February 13, 2025.
Anyone listening to the call is encouraged to read the company's periodic reports on file with the Securities and Exchange Commission, including the discussion of risk factors and historical results of operations and financial condition in those reports.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-release-fourth-quarter-and-full-year-2024-financial-results-on-january-30-2025-302337581.html
SOURCE Quest Diagnostics
FAQ
When will Quest Diagnostics (DGX) release Q4 and full year 2024 earnings?
What time is Quest Diagnostics (DGX) Q4 2024 earnings call?
How can investors access Quest Diagnostics (DGX) Q4 2024 earnings call?
Until when will Quest Diagnostics (DGX) Q4 2024 earnings call replay be available?
